Goldman Sachs ActiveBeta Europe Equity ETF (GSEU)

https://featureassets.gocomics.com/assets/0a63ee302714013fc072005056a9545d?optimizer=image&width=1200&quality=85

https://featureassets.gocomics.com/assets/0a63ee302714013fc072005056a9545d?optimizer=image&width=1200&quality=85

I'll tell you exactly why I tend to trust their analysis. They recommended Voyager Digital at ~.50 when they signed a marketing contract with them. The stock then went to ~$30 over the next 1.5-2 years. Voyager offered another contract and the NIA refused bc of what they saw in their most recent fin

With LunarD on our side, we Fly tomorrow

11, 77, 19, 38

Johnydollar.

You're absolutely right that DBMM is fighting organically. And I respect that framing. But here's the reality that organic growth runs into every single time:

Growth requires capital. Capital requires a share price that makes fundraising viable. And a share

No, patent approval (or notification) is expected before EOY 26. I think it's generally been a 31/2 - 4 year process and that began January 2023 for US. So we're 3 1/2 years and counting. Of course when / if patent approval, we will still need FDA approval but hopes are that it will be more quic

What does that have to do with where they are and what they are doing? Why do they need to be out of EM ?  
It makes a LOT of sense why they are still in EM.  

Hard worker good you mowed and saw mom get rested!

So you have a problem with their analysis? What specifically in what I posted do you find laughable or simply not possible? I don't do the whole fallacy thing.

I thought you only worked Monday through Friday

Is n't full patent approval 12-24 months away? Best we can hope for is notice of allowance by end of the year.

I agree. Still waiting to hear anything good regarding Amarin's direction and future. The old saying 'can't win for losing' certainly applies to Amarin. So, the LR patent, positive EMT2 as well as Recordati and Edding in China are the things we can hold to for now.

OK, let me be more direct. Speaking for myself, I couldn't in good faith post anything from NIA. I wouldn't trust it as evidence of anything other than proof there's a lot of garbage peddled on the internet. I fail to see how citing NIA strengthens any argument or serves any purpose other than as

When you combine revenues for full year 2025 from Bristol Meyer & Pfizer (joint distribution agreement), we get: $5.1B for Pfizer and $10.2B for Bristol Meyer.
That gives us roughly $15B total transfer market today. About double my initial estimate and roughly half of what IQVIA states from y

I totally agree.   
WRLGF deserves the terrible share price right now, but I do see a path to better days ahead.  

The 904 complex has some eye-popping results and has never been mined before.   However, that ore doesn't hit the mill until 2027.  

On the other ha

I fell asleep in my chair last night around 7:30 woke up at 12:30 tried to go to bed but couldn’t get back to sleep. I got up at 2am and loaded my truck up and headed to my mom’s place. Got there at 5 am and mowed the property. Went to get some stuff for my mom and stopped by to visit with her for a

I just hope I'm not going to have a hard time getting out of this stock...https://investorshub.advfn.com/uimage/uploads/2023/8/11/sdfxeiMarkup_20230811_163408.jpg

$IVDN News: Innovative Designs, Inc. (IVDN) Reaches Seven Trailing Quarters of Profitability on the Strength of Fiscal Q2 Revenue Growth as Superior Vacuum Cell Home Insulation Continues to Gain Wider Customer Base

Fiscal Q2 Will Be the Second Highest Quarterly Revenue in Company Hist

Thank you! 

$IVDN News: Innovative Designs, Inc. (IVDN) Reaches Seven Trailing Quarters of Profitability on the Strength of Fiscal Q2 Revenue Growth as Superior Vacuum Cell Home Insulation Continues to Gain Wider Customer Base

Fiscal Q2 Will Be the Second Highest Quarterly Revenue in Company Hist

Section 10(b) and Rule 10b-5 of the Securities Exchange Act of 1934

$BLIS News with $90 Million Guidance: NAPC Defense Advances Strategic Growth Initiatives, as Business Momentum Continues to Build and Company Remains on Track for Fiscal 2026 Annual Report

Shareholders encouraged to read recently released white paper

CLEARWATER, Fla., J

There may be life here in this penny stock if the company has a sponsor, no sponsor no life.